HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Deaf-Blind Disorders

The absence of both hearing and vision.
Also Known As:
Blindness-Deafness; Deaf-Blind Syndromes; Deaf-Blindness Disorders; Deaf-Mutism-Blind Disorders; Deafness-Blindness; Hearing and Vision Loss; Prelingual Deaf-Blind Disorders; Prelingual Deafness-Blindness; Vision and Hearing Loss; Blind Deaf Disorders; Blind-Deaf Disorder; Blindness Deafness; Deaf Blind Disorders; Deaf Blind Syndromes; Deaf Blindness Disorders; Deaf Mutism Blind Disorders; Deaf-Blind Disorder; Deaf-Blind Disorder, Prelingual; Deaf-Blind Disorders, Prelingual; Deaf-Blind Syndrome; Deaf-Blindness Disorder; Deaf-Mutism-Blind Disorder; Deafness Blindness; Deafness-Blindness, Prelingual; Deafness-Blindnesses, Prelingual; Disorder, Blind-Deaf; Disorder, Deaf-Blind; Disorder, Deaf-Blindness; Disorder, Deaf-Mutism-Blind; Disorder, Prelingual Deaf-Blind; Disorders, Blind-Deaf; Disorders, Deaf-Blind; Disorders, Deaf-Blindness; Disorders, Deaf-Mutism-Blind; Disorders, Prelingual Deaf-Blind; Prelingual Deaf Blind Disorders; Prelingual Deaf-Blind Disorder; Prelingual Deafness Blindness; Prelingual Deafness-Blindnesses; Syndrome, Deaf-Blind; Syndromes, Deaf-Blind; Blind-Deaf Disorders
Networked: 69 relevant articles (0 outcomes, 3 trials/studies)

Disease Context: Research Results

Related Diseases

1. Hearing Loss (Hearing Impairment)
2. Substance-Related Disorders (Drug Abuse)
3. Wounds and Injuries (Trauma)
4. Cerebral Palsy (Spastic Diplegia)
5. Usher Syndromes (Usher Syndrome)

Experts

1. Jentsch, Thomas J: 4 articles (01/2018 - 01/2008)
2. Petit, Christine: 3 articles (12/2019 - 08/2005)
3. Doyle, Lex W: 3 articles (01/2010 - 01/2009)
4. Ehrenkranz, Richard A: 3 articles (01/2010 - 01/2009)
5. Halliday, Henry L: 3 articles (01/2010 - 01/2009)
6. Doyle, L W: 3 articles (01/2003 - 01/2003)
7. Ehrenkranz, R A: 3 articles (01/2003 - 01/2003)
8. Halliday, H L: 3 articles (01/2003 - 01/2003)
9. Höbler, Fiona: 2 articles (10/2018 - 01/2016)
10. McGilton, Katherine S: 2 articles (10/2018 - 01/2016)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Deaf-Blind Disorders:
1. Proteins (Proteins, Gene)FDA Link
2. Oxygen (Dioxygen)IBA
01/21/2009 - "Data regarding clinical outcomes including mortality, CLD (including need for home oxygen, or need for late rescue with corticosteroids), death or CLD, failure to extubate, complications in the primary hospitalisation (including infection, hyperglycaemia, glycosuria, hypertension, echodensities on ultrasound scan of brain, necrotising enterocolitis (NEC), gastrointestinal (GI) bleeding, GI perforation, intraventricular hemorrhage (IVH), severe retinopathy of prematurity (ROP), and long-term outcomes (including blindness, deafness, cerebral palsy and major neurosensory disability), were abstracted and analysed using RevMan 5 Nineteen RCTs enrolling a total of 1345 participants were eligible for this review. "
01/01/2003 - "Data regarding clinical outcomes including mortality, CLD (including need for home oxygen, or need for late rescue with corticosteroids), death or CLD, failure to extubate, complications in the primary hospitalisation (including infection, hyperglycaemia, glycosuria, hypertension, echodensities on ultrasound scan of brain, necrotising enterocolitis (NEC), gastrointestinal bleeding, intestinal perforation, and severe retinopathy of prematurity (ROP)), and long term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability), were abstracted and analysed using RevMan 4.1. "
01/01/2003 - "Data regarding clinical outcomes including mortality, CLD (including late rescue with corticosteroids, or need for home oxygen therapy), death or CLD, failure to extubate, complications during the primary hospitalisation (including infection, hyperglycaemia, hypertension, hypertrophic cardiomyopathy, pneumothorax, severe intraventricular haemorrhage (IVH), necrotizing enterocolitis (NEC), gastrointestinal bleeding, and severe retinopathy of prematurity (ROP)), and long term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability), were abstracted and analysed using RevMan 4.1. "
01/20/2010 - "Data regarding clinical outcomes including mortality, CLD (including late rescue with corticosteroids, and need for home oxygen therapy), death or CLD, failure to extubate, complications during the primary hospitalisation (including infection, hyperglycaemia, hypertension, pulmonary air leak, patent ductus arteriosus (PDA), severe intraventricular haemorrhage (IVH), periventricular leucomalacia (PVL), necrotising enterocolitis (NEC), gastrointestinal bleeding, intestinal perforation, severe retinopathy of prematurity (ROP), and long-term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability) were abstracted and analysed using RevMan 5. Twenty-eight RCTs enrolling a total of 3740 participants were eligible for inclusion in this review. "
01/21/2009 - "Data regarding clinical outcomes including mortality, CLD (including late rescue with corticosteroids, and need for home oxygen therapy), death or CLD, failure to extubate, complications during the primary hospitalisation (including infection, hyperglycaemia, hypertension, pulmonary air leak, patent ductus arteriosus (PDA), severe intraventricular haemorrhage (IVH), periventricular leucomalacia (PVL), necrotising enterocolitis (NEC), gastrointestinal bleeding, intestinal perforation, severe retinopathy of prematurity (ROP), and long-term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability) were abstracted and analysed using RevMan 5. Twenty-eight RCTs enrolling a total of 3740 participants were eligible for inclusion in this review. "
3. Adrenal Cortex Hormones (Corticosteroids)IBA
01/21/2009 - "Data regarding clinical outcomes including mortality, CLD (including need for home oxygen, or need for late rescue with corticosteroids), death or CLD, failure to extubate, complications in the primary hospitalisation (including infection, hyperglycaemia, glycosuria, hypertension, echodensities on ultrasound scan of brain, necrotising enterocolitis (NEC), gastrointestinal (GI) bleeding, GI perforation, intraventricular hemorrhage (IVH), severe retinopathy of prematurity (ROP), and long-term outcomes (including blindness, deafness, cerebral palsy and major neurosensory disability), were abstracted and analysed using RevMan 5 Nineteen RCTs enrolling a total of 1345 participants were eligible for this review. "
01/01/2003 - "Data regarding clinical outcomes including mortality, CLD (including need for home oxygen, or need for late rescue with corticosteroids), death or CLD, failure to extubate, complications in the primary hospitalisation (including infection, hyperglycaemia, glycosuria, hypertension, echodensities on ultrasound scan of brain, necrotising enterocolitis (NEC), gastrointestinal bleeding, intestinal perforation, and severe retinopathy of prematurity (ROP)), and long term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability), were abstracted and analysed using RevMan 4.1. "
01/01/2003 - "Data regarding clinical outcomes including mortality, CLD (including late rescue with corticosteroids, or need for home oxygen therapy), death or CLD, failure to extubate, complications during the primary hospitalisation (including infection, hyperglycaemia, hypertension, hypertrophic cardiomyopathy, pneumothorax, severe intraventricular haemorrhage (IVH), necrotizing enterocolitis (NEC), gastrointestinal bleeding, and severe retinopathy of prematurity (ROP)), and long term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability), were abstracted and analysed using RevMan 4.1. "
01/20/2010 - "Data regarding clinical outcomes including mortality, CLD (including late rescue with corticosteroids, and need for home oxygen therapy), death or CLD, failure to extubate, complications during the primary hospitalisation (including infection, hyperglycaemia, hypertension, pulmonary air leak, patent ductus arteriosus (PDA), severe intraventricular haemorrhage (IVH), periventricular leucomalacia (PVL), necrotising enterocolitis (NEC), gastrointestinal bleeding, intestinal perforation, severe retinopathy of prematurity (ROP), and long-term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability) were abstracted and analysed using RevMan 5. Twenty-eight RCTs enrolling a total of 3740 participants were eligible for inclusion in this review. "
01/21/2009 - "Data regarding clinical outcomes including mortality, CLD (including late rescue with corticosteroids, and need for home oxygen therapy), death or CLD, failure to extubate, complications during the primary hospitalisation (including infection, hyperglycaemia, hypertension, pulmonary air leak, patent ductus arteriosus (PDA), severe intraventricular haemorrhage (IVH), periventricular leucomalacia (PVL), necrotising enterocolitis (NEC), gastrointestinal bleeding, intestinal perforation, severe retinopathy of prematurity (ROP), and long-term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability) were abstracted and analysed using RevMan 5. Twenty-eight RCTs enrolling a total of 3740 participants were eligible for inclusion in this review. "
4. Myosin VIIaIBA
5. Retinaldehyde (Retinal)IBA
6. SaltsIBA
7. Protein Isoforms (Isoforms)IBA
8. Cadherins (E-Cadherin)IBA
9. Myosins (Myosin)IBA
10. LipidsIBA

Therapies and Procedures

1. Surgical Amputation (Amputations)
2. Hearing Aids (Hearing Aid)
3. Terminal Care (Care, Terminal)
4. Therapeutics
05/29/2012 - "Secondary outcomes included mortality, cerebral palsy (CP), neurodevelopmental delay, blindness, deafness and main side effects of cooling therapy. "
01/01/2021 - "However, additional genes associated with HL and retinal impairment include ALMS1, TUBB4B, CEP78, ABHD12, and PRPS1 Accurate genetic diagnosis is critical to these individuals' understanding of their genetic conditions, prognosis, vision and hearing loss management, and future access to molecular therapies. "
01/01/2003 - "Data regarding clinical outcomes including mortality, CLD (including late rescue with corticosteroids, or need for home oxygen therapy), death or CLD, failure to extubate, complications during the primary hospitalisation (including infection, hyperglycaemia, hypertension, hypertrophic cardiomyopathy, pneumothorax, severe intraventricular haemorrhage (IVH), necrotizing enterocolitis (NEC), gastrointestinal bleeding, and severe retinopathy of prematurity (ROP)), and long term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability), were abstracted and analysed using RevMan 4.1. "
01/20/2010 - "Data regarding clinical outcomes including mortality, CLD (including late rescue with corticosteroids, and need for home oxygen therapy), death or CLD, failure to extubate, complications during the primary hospitalisation (including infection, hyperglycaemia, hypertension, pulmonary air leak, patent ductus arteriosus (PDA), severe intraventricular haemorrhage (IVH), periventricular leucomalacia (PVL), necrotising enterocolitis (NEC), gastrointestinal bleeding, intestinal perforation, severe retinopathy of prematurity (ROP), and long-term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability) were abstracted and analysed using RevMan 5. Twenty-eight RCTs enrolling a total of 3740 participants were eligible for inclusion in this review. "
01/21/2009 - "Data regarding clinical outcomes including mortality, CLD (including late rescue with corticosteroids, and need for home oxygen therapy), death or CLD, failure to extubate, complications during the primary hospitalisation (including infection, hyperglycaemia, hypertension, pulmonary air leak, patent ductus arteriosus (PDA), severe intraventricular haemorrhage (IVH), periventricular leucomalacia (PVL), necrotising enterocolitis (NEC), gastrointestinal bleeding, intestinal perforation, severe retinopathy of prematurity (ROP), and long-term outcome (including blindness, deafness, cerebral palsy and major neurosensory disability) were abstracted and analysed using RevMan 5. Twenty-eight RCTs enrolling a total of 3740 participants were eligible for inclusion in this review. "
5. Activities of Daily Living (ADL)